Michael Dennis Price

Michael Dennis Price has an estimated net worth of $2.96 Million. This is based on reported shares across multiple companies, which include NOVELION THERAPEUTICS INC., AKCEA THERAPEUTICS, INC., NOVEN PHARMACEUTICALS INC, and BENTLEY PHARMACEUTICALS INC.

2008 was Michael Dennis Price's most active year for acquiring shares with 16 total transactions. Michael Dennis Price's most active month to acquire stocks was the month of April. 2005 was Michael Dennis Price's most active year for disposing of shares, totalling 22 transactions. Michael Dennis Price's most active month to dispose stocks was the month of July. 2005 saw Michael Dennis Price paying a total of $1,315,927.63 for 384,000 shares, this is the most they've acquired in one year. In 2005 Michael Dennis Price cashed out on 533,882 shares for a total of $2,844,562.79, their largest year based on trade value.